To end the discussions with Maple Leaf, Mr. McAlpine, and Mr. Metzler, I know the key component is the regulatory burden. I know certainly with the Health Canada issue, they're not really looking at it from the perspective of the grower; they're looking at it from the perspective of the protection of consumers and so on with regard to pharmaceuticals. I hope the statement you went through, kind of explaining where the rest of the world is, will become a wake-up call, because that has been the key problem—getting overseas investors coming into Canada. The one advantage, when we are talking with people from other places in the world, and they say that maybe they won't come for oil and gas, and maybe they won't come for this is that agriculture still has a window there. But then they start looking at all of the other costs and all of the things that are associated with it, and they get nervous. With grain we had the transportation side. You get to the stage where you don't feel as though there's consistency there, and the same thing goes with many other things such as the seed regulations and so on. Are there specific regulatory changes that we could be looking at that would make it easier for you to speed your way through it?
Perhaps, Mr. McAlpine, you might have insight on that.